Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Immune cell atlas may improve survival predictions, guide treatment decisions in multiple myeloma

Immune cell atlas may improve survival predictions, guide treatment decisions in multiple myeloma

Newly identified rare genetic variant reduces the risk of leukemia

Newly identified rare genetic variant reduces the risk of leukemia

Epigenetic plasticity in germinal center B cells may help explain lymphoma origins

Epigenetic plasticity in germinal center B cells may help explain lymphoma origins

Combination therapy offers hope for AML patients facing drug resistance

Combination therapy offers hope for AML patients facing drug resistance

Researchers create the most detailed 3D maps of the human genome

Researchers create the most detailed 3D maps of the human genome

A senescence-based therapeutic approach for temporal lobe epilepsy

A senescence-based therapeutic approach for temporal lobe epilepsy

Precision immunotherapy for TRBC2-positive T-cell malignancies

Precision immunotherapy for TRBC2-positive T-cell malignancies

Revolutionary quantum sensors could enable earlier cancer diagnosis and treatment

Revolutionary quantum sensors could enable earlier cancer diagnosis and treatment

Chemotherapy may reduce HIV-infected T cells

Chemotherapy may reduce HIV-infected T cells

Global study finds stark differences in survival among children with cancer

Global study finds stark differences in survival among children with cancer

Combining inhibitors and chemotherapy enhances treatment for aggressive leukemia subtypes

Combining inhibitors and chemotherapy enhances treatment for aggressive leukemia subtypes

Researchers identify chromatin accessibility changes driving stem cell transformation in MDS

Researchers identify chromatin accessibility changes driving stem cell transformation in MDS

Two ongoing studies show promise of pivekimab sunirine in treating aggressive blood cancers

Two ongoing studies show promise of pivekimab sunirine in treating aggressive blood cancers

Pirtobrutinib shows superior outcomes compared to common first-line combination treatment for CLL/SLL

Pirtobrutinib shows superior outcomes compared to common first-line combination treatment for CLL/SLL

Small molecule discovery could open the door to new class of treatments for hard-to-treat cancers

Small molecule discovery could open the door to new class of treatments for hard-to-treat cancers

People exposed to Agent Orange face higher risk of developing myelodysplastic syndrome

People exposed to Agent Orange face higher risk of developing myelodysplastic syndrome

Highly sensitive CRISPR-based method designed to detect low-frequency cancer mutations

Highly sensitive CRISPR-based method designed to detect low-frequency cancer mutations

New antibody shows ability to overcome treatment resistance in blood cancers and solid tumors

New antibody shows ability to overcome treatment resistance in blood cancers and solid tumors

Genome-edited immune cell therapy shows promise for treating aggressive blood cancer

Genome-edited immune cell therapy shows promise for treating aggressive blood cancer

Timing of genetic mutation dictates childhood leukemia aggressiveness

Timing of genetic mutation dictates childhood leukemia aggressiveness

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.